Axsome Therapeutics
NY - New YorkBiotechnology
Focus: Axsome is a mid-cap biotechnology company focused on CNS treatments, particularly psychiatry and neurology indications. The company is headquartered in New York with 153 active open positions.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
150-20 this month
Contracting — net -20 jobs in 30d
46 added, 66 removed. Active reduction in progress.
Should You Work at Axsome Therapeutics?
AI assessmentStrong choice for commercial, medical affairs, and regulatory careers with revenue-generating assets; risky for R&D-focused scientists due to pipeline maturity and hiring imbalance.
Why Work Here
- Commercial-heavy growth phase: 133 of 153 open roles are in Commercial, signaling aggressive market expansion for approved products.
- Two peak-revenue products with extended exclusivity: AUVELITY (LOE 2043) and SUNOSI (LOE 2042) provide revenue runway and job security.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
16 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$34M Part DStable
Peak16.8yr
Help build intelligence for Axsome Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.